These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25008933)

  • 1. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
    Zhou B; Yang K; Wills E; Tang L; Baines JD
    J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
    Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
    Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations that decrease DNA binding of the processivity factor of the herpes simplex virus DNA polymerase reduce viral yield, alter the kinetics of viral DNA replication, and decrease the fidelity of DNA replication.
    Jiang C; Hwang YT; Randell JC; Coen DM; Hwang CB
    J Virol; 2007 Apr; 81(7):3495-502. PubMed ID: 17229696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV Integrase Inhibitor Raltegravir Inhibits Felid Alphaherpesvirus 1 Replication by Targeting both DNA Replication and Late Gene Expression.
    Pennington MR; Voorhees IEH; Callaway HM; Dehghanpir SD; Baines JD; Parrish CR; Van de Walle GR
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Burrel S; Deback C; Agut H; Boutolleau D
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
    Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
    Bestman-Smith J; Boivin G
    J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
    Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
    mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations.
    Duffy KE; Quail MR; Nguyen TT; Wittrock RJ; Bartus JO; Halsey WM; Leary JJ; Bacon TH; Sarisky RT
    BMC Infect Dis; 2002 May; 2():7. PubMed ID: 12019036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.
    Burrel S; Aït-Arkoub Z; Agut H; Boutolleau D
    Antiviral Res; 2012 Jan; 93(1):199-203. PubMed ID: 22061617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G; Gillemot S; Topalis D; Snoeck R
    J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity.
    Jiang C; Komazin-Meredith G; Tian W; Coen DM; Hwang CB
    J Virol; 2009 Aug; 83(15):7573-80. PubMed ID: 19474109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of polymerase to herpes simplex virus type 1 replication foci in cells expressing mutant primase (UL52) proteins.
    Carrington-Lawrence SD; Weller SK
    J Virol; 2003 Apr; 77(7):4237-47. PubMed ID: 12634381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Subunit of the Human Herpes Simplex Virus Terminase as a Promising Target in Design of Anti-Herpesvirus Agents.
    Krasnov VP; Andronova VL; Belyavsky AV; Borisevich SS; Galegov GA; Kandarakov OF; Gruzdev DA; Vozdvizhenskaya OA; Levit GL
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Zarrouk K; Zhu X; Pham VD; Goyette N; Piret J; Shi R; Boivin G
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0039021. PubMed ID: 33875432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
    Zhong L; Hayward GS
    J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.